Ethnic differences in patients with Brugada syndrome and arrhythmic events: New insights from Survey on Arrhythmic Events in Brugada Syndrome.


Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
10 2019
Historique:
received: 18 06 2019
pubmed: 10 7 2019
medline: 2 12 2020
entrez: 9 7 2019
Statut: ppublish

Résumé

There is limited information on ethnic differences between patients with Brugada syndrome (BrS) and arrhythmic events (AEs). The purpose of this study was to compare clinical, electrocardiographic (ECG), electrophysiological, and genetic characteristics between white and Asian patients with BrS and AEs. The Survey on Arrhythmic Events in Brugada Syndrome is a multicenter survey from Western and Asian countries, gathering 678 patients with BrS and first documented AE. After excluding patients with other (n = 14 [2.1%]) or unknown (n = 30 [4.4%]) ethnicity, 364 (53.7%) whites and 270 (39.8%) Asians comprised the study group. There was no difference in AE age onset (41.3 ± 16.1 years in whites vs 43.3 ± 12.3 years in Asians; P = .285). Higher proportions of whites were observed in pediatric and elderly populations. Asians were predominantly men (98.1% vs 85.7% in whites; P < .001) and frequently presented with aborted cardiac arrest (71.1% vs 56%; P < .001). Asians tended to display more spontaneous type 1 BrS-ECG pattern (71.5% vs 64.3%; P = .068). A family history of sudden cardiac death was noted more in whites (29.1% vs 11.5%; P < .001), with a higher rate of SCN5A mutation carriers (40.1% vs 13.2% in Asians; P < .001), as well as more fever-related AEs (8.5% vs 2.9%; P = .011). No difference was observed between the 2 groups regarding history of syncope and ventricular arrhythmia inducibility. There are important differences between Asian and white patients with BrS. Asian patients present almost exclusively as male adults, more often with aborted cardiac arrest and spontaneous type 1 BrS-ECG. However, they have less family history of sudden cardiac death and markedly lower SCN5A mutation rates. The striking difference in SCN5A mutation rates should be tested in future studies.

Sections du résumé

BACKGROUND
There is limited information on ethnic differences between patients with Brugada syndrome (BrS) and arrhythmic events (AEs).
OBJECTIVE
The purpose of this study was to compare clinical, electrocardiographic (ECG), electrophysiological, and genetic characteristics between white and Asian patients with BrS and AEs.
METHODS
The Survey on Arrhythmic Events in Brugada Syndrome is a multicenter survey from Western and Asian countries, gathering 678 patients with BrS and first documented AE. After excluding patients with other (n = 14 [2.1%]) or unknown (n = 30 [4.4%]) ethnicity, 364 (53.7%) whites and 270 (39.8%) Asians comprised the study group.
RESULTS
There was no difference in AE age onset (41.3 ± 16.1 years in whites vs 43.3 ± 12.3 years in Asians; P = .285). Higher proportions of whites were observed in pediatric and elderly populations. Asians were predominantly men (98.1% vs 85.7% in whites; P < .001) and frequently presented with aborted cardiac arrest (71.1% vs 56%; P < .001). Asians tended to display more spontaneous type 1 BrS-ECG pattern (71.5% vs 64.3%; P = .068). A family history of sudden cardiac death was noted more in whites (29.1% vs 11.5%; P < .001), with a higher rate of SCN5A mutation carriers (40.1% vs 13.2% in Asians; P < .001), as well as more fever-related AEs (8.5% vs 2.9%; P = .011). No difference was observed between the 2 groups regarding history of syncope and ventricular arrhythmia inducibility.
CONCLUSION
There are important differences between Asian and white patients with BrS. Asian patients present almost exclusively as male adults, more often with aborted cardiac arrest and spontaneous type 1 BrS-ECG. However, they have less family history of sudden cardiac death and markedly lower SCN5A mutation rates. The striking difference in SCN5A mutation rates should be tested in future studies.

Identifiants

pubmed: 31284050
pii: S1547-5271(19)30635-6
doi: 10.1016/j.hrthm.2019.07.003
pii:
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1468-1474

Informations de copyright

Copyright © 2019 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Anat Milman (A)

Leviev Heart Institute, The Chaim Sheba Medical Center, Tel Hashomer, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Antoine Andorin (A)

L'institut du Thorax, Service de Cardiologie, CHU de Nantes, Nantes, France; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART).

Pieter G Postema (PG)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART); Heart Centre AMC, Department of Clinical and Experimental Cardiology, AMC, University of Amsterdam, Amsterdam, The Netherlands.

Jean-Baptiste Gourraud (JB)

L'institut du Thorax, Service de Cardiologie, CHU de Nantes, Nantes, France; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART).

Frederic Sacher (F)

Hôpital Cardiologique du Haut-Lévêque and Université Bordeaux, LIRYC Institute, Bordeaux, France.

Philippe Mabo (P)

Cardiology and Vascular Disease Division, Rennes University Health Centre, Rennes, France.

Sung-Hwan Kim (SH)

Division of Cardiology, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Shingo Maeda (S)

Heart Rhythm Center, Tokyo Medical and Dental University, Tokyo, Japan.

Yoshihide Takahashi (Y)

Heart Rhythm Center, Tokyo Medical and Dental University, Tokyo, Japan.

Tsukasa Kamakura (T)

Division of Arrhythmia and Electrophysiology, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.

Takeshi Aiba (T)

Division of Arrhythmia and Electrophysiology, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.

Giulio Conte (G)

Heart Rhythm Management Centre, UZ-VUB, Brussels, Belgium.

Jimmy J M Juang (JJM)

Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.

Eran Leshem (E)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel; Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Yoav Michowitz (Y)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Rami Fogelman (R)

Department of Pediatric Cardiology, Schneider Children's Medical Center, Petach Tikva, Israel.

Aviram Hochstadt (A)

Department of Internal Medicine J, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.

Yuka Mizusawa (Y)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART); Heart Centre AMC, Department of Clinical and Experimental Cardiology, AMC, University of Amsterdam, Amsterdam, The Netherlands.

Carla Giustetto (C)

Division of Cardiology, University of Torino, Department of Medical Sciences, Città della Salute e della Scienza Hospital, Torino, Italy.

Elena Arbelo (E)

Cardiovascular Institute, Hospital Clinic and IDIBAPS, Barcelona, Catalonia, Spain.

Zhengrong Huang (Z)

Department of Cardiology, the First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China.

Domenico Corrado (D)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART); Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, Italy.

Pietro Delise (P)

Division of Cardiology, Hospital of Peschiera del Garda, Veneto, Italy.

Giuseppe Allocca (G)

Division of Cardiology, Hospital of Peschiera del Garda, Veneto, Italy.

Masahiko Takagi (M)

Division of Cardiac Arrhythmia, Kansai Medical University Medical Center, Moriguchi, Japan.

Yanushi D Wijeyeratne (YD)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART); Cardiovascular Sciences, St. George's University of London, Cardiology Clinical Academic Group, St. George's University Hospitals NHS Foundation Trust, London, United Kingdom.

Andrea Mazzanti (A)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART); Molecular Cardiology, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.

Ramon Brugada (R)

Cardiovascular Genetics Center, University of Girona-IDIBGI, Girona, Spain; Medical Science Department, School of Medicine, University of Girona, Girona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.

Ruben Casado-Arroyo (R)

Department of Cardiology, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.

Jean Champagne (J)

Quebec Heart and Lung Institute, Quebec City, Quebec, Canada.

Leonardo Calo (L)

Division of Cardiology, Policlinico Casilino, Rome, Italy.

Georgia Sarquella-Brugada (G)

Pediatric Arrhythmias, Electrophysiology and Sudden Death Unit Cardiology, Department Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain.

Camilla H Jespersen (CH)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART); The Heart Centre, Copenhagen University Hospital, Copenhagen, Denmark; Department of Forensic Medicine, Faculty of Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Jacob Tfelt-Hansen (J)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART); The Heart Centre, Copenhagen University Hospital, Copenhagen, Denmark; Department of Forensic Medicine, Faculty of Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Christian Veltmann (C)

Division of Rhythmology and Electrophysiology, Department of Cardiology, Hannover Medical School, Hannover, Germany.

Silvia G Priori (SG)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART); Molecular Cardiology, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.

Elijah R Behr (ER)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART); Cardiovascular Sciences, St. George's University of London, Cardiology Clinical Academic Group, St. George's University Hospitals NHS Foundation Trust, London, United Kingdom.

Gan-Xin Yan (GX)

Lankenau Medical Center, Wynnewood, Pennsylvania.

Josep Brugada (J)

Cardiovascular Institute, Hospital Clinic and IDIBAPS, Barcelona, Catalonia, Spain.

Fiorenzo Gaita (F)

Division of Cardiology, University of Torino, Department of Medical Sciences, Città della Salute e della Scienza Hospital, Torino, Italy.

Arthur A M Wilde (AAM)

European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART); Heart Centre AMC, Department of Clinical and Experimental Cardiology, AMC, University of Amsterdam, Amsterdam, The Netherlands.

Pedro Brugada (P)

Heart Rhythm Management Centre, UZ-VUB, Brussels, Belgium.

Kengo F Kusano (KF)

Division of Arrhythmia and Electrophysiology, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.

Kenzo Hirao (K)

Heart Rhythm Center, Tokyo Medical and Dental University, Tokyo, Japan.

Gi-Byoung Nam (GB)

Division of Cardiology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Vincent Probst (V)

L'institut du Thorax, Service de Cardiologie, CHU de Nantes, Nantes, France; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARDHEART).

Bernard Belhassen (B)

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Heart Institute, Hadassah University Hospital, Jerusalem, Israel. Electronic address: bblhass@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH